Long COVID

SAN DIEGO — Patients with rheumatoid arthritis who reported having long COVID in the past year demonstrated “many symptoms” of long COVID prior to initial infection,” according to data presented at ACR Convergence 2023.

Brain fog and other long COVID symptoms could arise from depleted serotonin triggered by persistent SARS-CoV-2 infection in the gut, supporting the study of selective serotonin reuptake inhibitors for treatment of long COVID.

A new study links some neurocognitive symptoms of long COVID to persistent SARS-CoV-2 infection in the gut, which triggers a series of reactions that lowers serotonin levels.

COVID-19 vaccination was associated with a reduced likelihood of long COVID among children infected with SARS-CoV-2 during the omicron wave, according to study findings presented at IDWeek.

Half of patients with long COVID demonstrate persistent inflammation and may potentially benefit from immunomodulation, according to data.

Fewer than one in four U.S. adults are concerned about influenza, COVID-19 or respiratory syncytial virus infection, according to an annual survey administered by the National Foundation for Infectious Diseases.

In 2022, more than one in 20 adults in the United States reported ever having long COVID, with women more likely than men to report lingering COVID-19 symptoms months after infection, a CDC survey found.

As of last year, around one in 100 children in the United States had ever had long COVID, according to survey findings reported by the CDC’s National Center for Health Statistics.

Exercise-based rehabilitation interventions were associated with improvements in quality of life and functional exercise capacity for patients with long COVID, according to the results of a meta-analysis published in JAMA Network Open.